Sponsor or institution
Clinical trials and research at Jecho Biopharmaceuticals Co., Ltd.
As of November 12, 2026, Find a Trial lists 5 clinical trials run by Jecho Biopharmaceuticals Co., Ltd. that are recruiting, in China. By phase: Phase 1 (3), Phase 1/2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| JLM019 Injection in Adults with Advanced Cancers | Phase 1 | Beijing, Beijing Municipality | Recruiting | Jun 3, 2026 |
| JL19001 Injection Alone or with Standard Therapy in Advanced Solid Tumors or Relapsed/Refractory B-Cell NHL | Phase 1 | Beijing, Beijing Municipality | Recruiting | May 22, 2026 |
| JL18008 added to existing HIV therapy in people who have not rebuilt their CD4 cells | Phase 1/2 | Beijing, Beijing Municipality | Recruiting | May 12, 2026 |
| JL15003 injection for adults with recurrent glioblastoma | Phase 1/2 | Shanghai | Recruiting | Mar 30, 2026 |
| JL19001 Injection for High-Risk NMIBC (alone or with BCG) | Phase 1 | Chengdu, Sichuan | Recruiting | Mar 19, 2026 |
All recruiting trials (5)
-
JLM019 Injection in Adults with Advanced Cancers
This study tests JLM019 Injection in adults with advanced solid tumors or relapsed/refractory lymphomas to see if it’s safe and tolerable.
-
JL19001 Injection Alone or with Standard Therapy in Advanced Solid Tumors or Relapsed/Refractory B-Cell NHL
This phase 1 trial tests JL19001 by itself or with standard treatment to see if it is safe and tolerable in adults with advanced solid tumors or relapsed/refractory B-cell non-Hodgkin lymphoma.
-
JL18008 added to existing HIV therapy in people who have not rebuilt their CD4 cells
This trial tests whether adding JL18008 to current HIV treatment helps people with HIV who have low CD4 counts despite good viral control.
-
JL15003 injection for adults with recurrent glioblastoma
This trial will test JL15003 injection in adults with recurrent glioblastoma to see if it can slow tumor growth.
-
JL19001 Injection for High-Risk NMIBC (alone or with BCG)
This early-stage study tests different doses of JL19001 injections to see if they are safe and tolerable in adults with high-risk non-muscle invasive bladder cancer.
Quick answers
How many clinical trials run by Jecho Biopharmaceuticals Co., Ltd. are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 3, Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.